Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity

Medical Physics

Volumn 32, Issue 7, 2005, Pages 2189-2192

  Ling, C Clifton ^a   Li, X Allen ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE; RADIATION TREATMENT PLANNING; SURROGATE MEASURES; TUMOR CELLS;

CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIOBIOLOGY; REVIEW; TREATMENT PLANNING; TUMOR CELL;

EID: 22544464126     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1930908     Document Type: Review

References (18)

1. S. Levegrun, A. Jackson, M. J. Zelefsky, E. S. Venkatraman, M. W. Skwarchuk, W. Schlegel, Z. Fuks, S. A. Leibel, and C. C. Ling, "Risk group dependence of dose response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer," Radiother. Oncol. 63, 11-26 (2002).
2. E. D. Yorke, A. Jackson, K. E. Rosenzweig, S. A. Merrick, D. Gabrys, E. S. Venkatraman, C. M. Burman, S. A. Leibel, and C. C. Ling, "Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small lung cancer patients treated with three-dimensional conformal radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 54, 329-339 (2002).
3. A. Jackson, M. W. Skwaarchuk, M. J. Zelefsky, D. M. Cowen, E. S. Venkatraman, S. Levegrun, C. M. Burman, G. J. Kutcher, Z. Fuks, S. A. Liebel, and C. C. Ling, "Late rectal bleeding after conformal radiotherapy of prostate cancer II: Volume effects and dose-volume histograms," Int. J. Radiat. Oncol., Biol., Phys. 49, 685-698 (2001).
4. A. Niemierko, "Reporting and analyzing dose distributions: A concept of equivalent uniform dose," Med. Phys. 24, 103-110 (1997).
5. R. Withers, J. Taylor, and B. Maciejewski, "Treatment volume and tissue tolerance," Int. J. Radiat. Oncol., Biol., Phys. 14, 751-759 (1988).
6. C. N. Coleman, "Radiation oncology-linking technology and biology in the treatment of cancer," Acta Oncol. 41, 6-13 (2001).
7. E. Nakata, N. Hunter, K. Mason, Z. Fan, K. K. Ang, and L. Milas, "C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy," Int. J. Radiat. Oncol., Biol., Phys. 59, 1163-1173 (2004).
8. K. S. C. Chao et al., "A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 49, 1171-1182 (2001).
9. F. Blankenberg, C. Mari, and H. W. Strauss, "Imaging cell death in vivo," Q. J. Nucl. Med. 47, 337-348 (2003).
10. C. Cohade and R. Wahl, "PET scanning and measuring the impact of treatment" Cancer J. 8, 119-134 (2002).
11. K. L. Zakian, J. A. Koutcher, D. Ballon, H. Hricak, and C. C. Ling, "Developments in nuclear magnetic resonance imaging and spectroscopy: application to oncology," Semin. Radiat. Oncol. 11, 3-15 (2001).
12. T. E. Schultheiss, "The controversies and pitfalls in modeling normal tissue radiation injury/damage," Semin. Radiat. Oncol. 11, 210-214 (2001).
13. D. J. Carlson, R. D. Stewart, X. A. Li, K. Jennings, J. Z. Wang, and M. Guerrero, "Comparison of in vitro and in vivo α/β ratios for prostate cancer," Phys. Med. Biol. 49, 4477-4491 (2004).
14. S. Webb, P. M. Evans, W. Swindell, and J. O. Deasy, "A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume," Phys. Med. Biol. 39, 2091-2098 (1994).
15. J. Z. Wang, M. Guerrero, and X. A. Li, "How low is the α/β ratio for prostate cancer?" Int. J. Radiat. Oncol., Biol., Phys. 55, 194-203 (2003).
16. M. Guerrero and X. A. Li, "Deriving radiobiological parameters from a large number of clinical studies for radiotherapy treatment planning of early-stage breast cancer," Phys. Med. Biol. 48, 3307-3326 (2003).
17. J. Z. Wang, X. A. Li, W. D'Souza, and R. D. Stewart., "Impacts of prolonged dose-delivery time on tumor control: A note of caution for IMRT," Int., J. Radiat. Oncol., Biol., Phys. 57, 543-552 (2003).
18. S. Apisarnthanarax and K. S. C. Chao, "Current imaging paradigms in radiation oncology," Radiat. Res. 163, 1-25 (2005).